Type 2 diabetes is a serious condition that can lead to life-threatening complications. However, by adopting effective management strategies, there is a good chance that many people with type 2 diabetes can expect to live as long as a person without the disease. Type 2 diabetes usually appears later in life, although the incidence in younger people is increasing. The disease, which is characterized by high blood glucose (sugar) levels or hyperglycemia, is usually the result of a combination of unhealthy lifestyle habits, obesity, and genes.
Over time, untreated hyperglycemia can lead to serious, life-threatening complications. Type 2 diabetes also puts you at risk for certain health conditions that may reduce your life expectancy. However, there is good news: people with type 1 diabetes are known to live with this condition for more than 85 years. As noted above, recent studies on life expectancy show significant improvement in life expectancy rates for people with type 1 diabetes born later in the 20th century.
Although there is no cure for type 2 diabetes, studies show that it is possible for some people to reverse it. Through dietary changes and weight loss, you may be able to achieve and maintain normal blood sugar levels without medication. After the analysis, the researchers found that the average person with type 1 diabetes was 42.8 years old and a life expectancy as of now of 32.6 years. By comparison, people of the same age without diabetes were expected to live 40.2 years from now.
For type 2 diabetes, the average patient was 65.4 years old and had a life expectancy as of now of 18.6 years. In comparison, patients of the same age without diabetes were expected to live within 20.3 years. How quickly diabetes was diagnosed, the progress of diabetic complications, and whether one has other existing conditions will contribute to life expectancy, regardless of whether the person concerned has type 1 or type 2 diabetes. Patients with type 1 DM and type 2 DM are expected to have a half-life of 70.96 and 75.19 years at the end of the observed period.
Evidence-based behavior change app approved by the NHS for people with type 2 diabetes, prediabetes, obesity and those looking to optimize their health and well-being. Published in a major journal on diabetes, Diabetes, Obesity and Metabolism, by scientists at Cardiff University, the study set out to compare the survival of diabetic patients who were prescribed metformin with that of patients who were prescribed another common diabetes medication. Patients with type 2 DM have a longer life expectancy than patients with type 1 DM and the overall life expectancy of diabetics is equal to that of the non-diabetic population, which could suggest better control of the disease and its associated complications in Bulgaria. For each time interval, the probability of survival is calculated as the number of surviving subjects divided by the number of patients at risk.
On average, having type 2 diabetes has been found to reduce life expectancy by up to 10 years. The stratification of the diabetic and non-diabetic population by type of diabetes and sex provides an interesting insight into the dynamics. For the type 2 male population, LE is higher than that of the non-diabetic male population, however, in the non-diabetic female population it is higher than the life expectancy of type 2 diabetic women. The same is observed when analyzing only male populations, however, for women the probability of survival begins to decrease between 60 and 64 years, equaling 65 years and, subsequently, falling well below the probability of survival in the non-diabetic female population.
It is still logical that, for both type 1 and type 2 diabetes, female life expectancy is increasing, and the data clearly show that this contrasts with the stagnation of LE in the non-diabetic female population. The risk of stroke was more than three times higher in men and women aged 40 and younger diagnosed with type 2 diabetes, while the risk of atrial fibrillation was twice as high. Previous studies have shown that younger people with type 2 diabetes have a higher risk of cardiovascular disease, but those tests did not compare mortality risks from the time of diagnosis, according to the researchers. While if you develop type 2 diabetes at the other end of the age spectrum, at age 80, you don't lose any life expectancy.
However, the average expected LE in patients with type 2 diabetes is higher compared to the LE in the non-diabetic population, while the average LE for type 1 patients is almost 4 years lower. . .